CFGS
GBT

Concourse Financial Group Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Concourse Financial Group Securities’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-430
Closed -$29K – 2377
2022
Q3 		$29K Hold
430
– – ﹤0.01% 1167
2022
Q2 		$14K Buy
430
+165
+62% +$4.83K ﹤0.01% 1574
2022
Q1 		$9K Sell
265
-175
-40% -$5.23K ﹤0.01% 1737
2021
Q4 		$13K Sell
440
-15
-3% -$465 ﹤0.01% 1795
2021
Q3 		$12K Hold
455
– – ﹤0.01% 1847
2021
Q2 		$16K Buy
455
+165
+57% +$6.44K ﹤0.01% 1722
2021
Q1 		$12K Hold
290
– – ﹤0.01% 1731
2020
Q4 		$13K Buy
290
+15
+5% +$740 ﹤0.01% 1619
2020
Q3 		$15K Hold
275
– – ﹤0.01% 1458
2020
Q2 		$17K Hold
275
– – ﹤0.01% 1359
2020
Q1 		$14K Hold
275
– – ﹤0.01% 1363
2019
Q4 		$22K Buy
275
+100
+57% +$5.93K ﹤0.01% 1227
2019
Q3 		$8K Hold
175
– – ﹤0.01% 1224
2019
Q2 		$9K Buy
+175
New +$10.1K ﹤0.01% 1538

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Concourse Financial Group Securities's GBT Position: Q4 2022 in Review

Concourse Financial Group Securities sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 430 shares — an estimated $29K sold.

Concourse Financial Group Securities first reported a position in GBT in Q2 2019 and held it in 14 quarters. The position peaked at $29K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Concourse Financial Group Securities reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 430 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $29K.
  • Concourse Financial Group Securities first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 14 quarters.
  • Concourse Financial Group Securities's Global Blood Therapeutics, Inc. position peaked at $29K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Concourse Financial Group Securities's 13F filing for Q4 2022, filed 30 Jan 2023.